Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

MSD Australia & New Zealand is astonished that after eight years of dialogue and consideration, the Pharmaceutical Benefits Advisory Committee (PBAC ...

Luke FaulksLocal Journalism Initiative ReporterPique NewsmagazineA Pemberton resident and her family are appealing to the ...

Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...

The interventions being tested include Trastuzumab deruxtecan (T-DXd), an experimental therapy, combined with either Rilvegostomig or Pembrolizumab, both administered via intravenous infusion. These ...

"Prior to the EV-302 clinical trial, the treatment of advanced bladder cancer treatment hadn't significantly changed since ...

A significant breakthrough in advanced bladder cancer treatment has been approved for use on the NHS, offering renewed hope ...

This article highlights recent research on breast cancer, lung cancer, melanoma, head and neck cancer, and hematologic malignancies.

UCLA’s cancer research has been deeply impactful, with millions of people receiving drugs and therapies developed in Bruin ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

Padcev-Keytruda will now join Bristol Myers Squibb’s Opdivo in the list of bladder cancer drugs available on the NHS.